34039-36-6

Basic information

• Product Name: 4-METHOXYBUTYLAMINE
• Synonyms: 4-METHOXYBUTYLAMINE
• CAS NO: 34039-36-6
• Molecular Formula: C₅H₁₃NO
• Molecular Weight: 103.16
• Mol File: 34039-36-6.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-METHOXYBUTYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-METHOXYBUTYLAMINE(34039-36-6)
• EPA Substance Registry System: 4-METHOXYBUTYLAMINE(34039-36-6)

Safety Data

• Hazardous Substances Data: 34039-36-6(Hazardous Substances Data)

Usage

General Description

4-Methoxybutylamine is a chemical compound known for its use in the synthesis of various pharmaceuticals and as an intermediate in organic synthesis. Characterized by the formula C5H13NO, this compound belongs to the class of organic compounds known as amines, which contain a nitrogen atom attached to one or more hydrocarbons. It's a liquid at room temperature and exhibits characteristics typically associated with amines, such as a pungent smell. Being an industrial-grade compound, 4-Methoxybutylamine needs to be handled with care due to its potential to cause skin and eye irritation and harm to the respiratory system if inhaled.

Upstream product

• 67-56-1 methanol 
• 57371-37-6 4-methoxy-1-butyronitrile 
• 143142-77-2 2-(4-methoxybutyl)-1H-isoindole-1,3(2H)-dione 
• 1093860-21-9 4-azidobutyl methyl ether 
• 17913-18-7 4-(methoxy)-1-chlorobutane 

Downstream Products

• 108842-71-3 1-(4-methoxy-butyl)-4-(2-methoxy-phenyl)-piperazine 
• 7616-02-6 1-(4-Methoxy-butylamino)-3-methyl-3-phenoxy-butan-2-ol 
• 7616-00-4 1-(4-Methoxy-butylamino)-3-phenoxy-butan-2-ol 
• 7615-98-7 1-(4-Methoxy-butylamino)-3-phenoxy-propan-2-ol 
• 671225-75-5 (S)-3-(3,4-Dimethoxy-phenyl)-3-[2-(4-methoxy-butylamino)-acetylamino]-propionic acid methyl ester 
• 34317-40-3 (4-Methoxy-butyl)-methyl-amine 
• 788-89-6 N-Nitroso-N-<4-methoxy-butyl>-p-toluolsulfonamid 
• 1093860-29-7 phenylmethyl (2-{(6-chloro-3'-ethyl-2-biphenylyl)[4-(methyloxy)butyl]amino}-2-oxoethyl)methylcarbamate 

Relevant articles and documents

RENIN INHIBITORS

The present invention is directed to aspartic protease inhibitors. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.

Process for the preparation of 2-nitrobenzaldehydes

The new process for the preparation of 2-nitrobenzaldehydes of the general formula STR1 in which X1 and X2 either independently of one another represent hydrogen or halogen or one of the substituents represents nitro and the other substituent then represents hydrogen, by oxidation of 2-nitrotoluenes of the general formula STR2 in which X1 and X2 have the meaning indicated above is characterized in that the oxidation with oxygen or an oxygen-containing gas is carried out in the presence of at least one alkoxyalkylamine as a solvent and in the presence of strong bases.